Mr. James Howard-Tripp reports
STAGEZERO ANNOUNCES 2ND QUARTER 2019 INVESTOR CALL
Stagezero Life Sciences Ltd. will release its second quarter 2019 operational results before market open on Wednesday, Aug. 14, 2019. Stagezero's chairman and chief executive officer, James R. Howard-Tripp, will host a conference call at 8:30 a.m. ET on Aug. 14, 2019, to review the operational results and discuss business developments for the period.
Date: Wednesday, Aug. 14, 2019
Participant dial-in: 844-602-0380
International dial-in: 862-298-0970
Replay number: 877-481-4010
International replay: 919-882-2331
Replay code: 53250
Teleconference replay expiration: Aug. 21, 2019
About Stagezero Life Sciences Ltd.
Stagezero Life is dedicated to the early detection of cancer and multiple disease states through whole blood. Its next-generation test, Aristotle, is a multicancer panel for simultaneously screening for 10 cancers from a single sample of blood, with high sensitivity and specificity for each cancer. Aristotle is built on the company's proven and proprietary Sentinel Principle technology platform, which was validated on 10,000 patients and used to develop the first liquid biopsy for colorectal cancer.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.